A historical overview of leprosy epidemiology and control activities in Amazonas, Brazil by Cunha, Carolina et al.
Revista da Sociedade Brasileira de Medicina Tropical
 This is an open-access artcle distributed under the terms of the rreatve rommons 
Attributon License  nonteɴ httpɴ//wwwwww scielo br/scielo phpcscript=sci_arttextppid=S007+-
86822015000800055plng=enpnrm=iso  Acesso emɴ 9 maio 2018 
REnERÊNrIA
rUNHA, rarolina et al  A historical overvieww of leprosy epidemiology and control actvites in 
Amazonas, Brazil  Revista da Sociedade Brasileira de Medicina Tropical, Uberaba, v  48, supl  1, p  
55-62, jun  2015  Disponível emɴ <httpɴ//wwwwww scielo br/scielo phpcscript=sci_arttextppid=S007+-
86822015000800055plng=enpnrm=iso>  Acesso emɴ 9 maio 2018  doiɴ 
httpɴ//dx doi org/10 1590/007+-8682-0107-2017 
  55www.scielo.br/rsbmt I www.rsbmt.org.br
Revista da Sociedade Brasileira de Medicina Tropical 48(Suppl I):55-62, 2015
http://dx.doi.org/10.1590/0037-8682-0103-2013 Review Article
Corresponding author: Dra. Carolina Talhari. Fundação Alfredo da Matta. 
Rua Codajás 24, Cachoeirinha, 69065-139 Manaus, AM. 
Phone/Fax: 55 92 3632-5853
e-mail: carolinatalhari@gmail.com
Received 9 May 2014
Accepted 12 September 2014
A historical overview of leprosy epidemiology 
and control activities in Amazonas, Brazil
Carolina Cunha[1], Valderiza Lourenço Pedrosa[1], Luiz Carlos Dias[1], Andréa Braga[2], 
Anette Chrusciak-Talhari[2],[5], Mônica Santos[1],[5], Gerson Oliveira Penna[3], 
Sinésio Talhari[4] and Carolina Talhari[1],[5]
[1]. Departamento de Dermatologia, Fundação de Dermatologia e Venereologia Alfredo da Matta, Manaus, AM. [2]. Departamento de Dermatologia, Fundação 
de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, AM. [3]. Departamento de Dermatologia, Centro de Medicina Tropical, Universidade de Brasília, 
Brasília, DF. [4]. Departamento de Dermatologia, Universidade Nilton Lins, Manaus, AM. [5]. Programa de Pós-Graduação em Medicina Tropical , Universidade 
do Estado do Amazonas, Manaus, AM.
ABSTRACT 
Leprosy is an ancient infectious disease caused by Mycobacterium leprae. According to comparative genomics studies, this 
disease originated in Eastern Africa or the Near East and spread with successive human migrations. The Europeans and North 
Africans introduced leprosy into West Africa and the Americas within the past 500 years. In Brazil, this disease arrived with 
the colonizers who disembarked at the ﬁ rst colonies, Rio de Janeiro, Salvador and Recife, at the end of the sixteenth century, 
after which it was spread to the other states. In 1854, the ﬁ rst leprosy cases were identiﬁ ed in State of Amazonas in the north 
of Brazil. The increasing number of leprosy cases and the need for treatment and disease control led to the creation of places to 
isolate patients, known as leprosaria. One of them, Colonia Antônio Aleixo was built in Amazonas in 1956 according to the most 
advanced recommendations for isolation at that time and was deactivated in 1979. The history of the Alfredo da Matta Center 
(AMC), which was the ﬁ rst leprosy dispensary created in 1955, parallels the history of leprosy in the state. Over the years, the 
AMC has become one of the best training centers for leprosy, general dermatology and sexually transmitted diseases in Brazil. 
In addition to being responsible for leprosy control programs in the state, the AMC has carried out training programs on leprosy 
diagnosis and treatment for health professionals in Manaus and other municipalities of the state, aiming to increase the coverage 
of leprosy control activities. This paper provides a historical overview of leprosy in State of Amazonas, which is an endemic 
state in Brazil.
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INTRODUCTION
Leprosy is a chronic infectious disease caused by 
Mycobacterium leprae. It mainly affects the skin and peripheral 
nervous system. Depending on the type of leprosy, involvement 
of the reticuloendothelial system, bones and joints, mucous 
membranes, eyes, testes, muscles, adrenals and other areas 
may occur(1). Transmission occurs between humans through 
prolonged and close contact, and untreated patients present 
with the multibacillary types of the disease(2). Aerosol spread 
of nasal discharge and uptake through the nasal or respiratory 
mucosa are likely the principal modes of transmission(3). The 
nose and respiratory system are not only the ports of exit but 
are also regarded as the main ports of entry for this disease(4). 
Transmission is assumed to occur directly from an infected 
person to another person; however, indirect routes cannot be 
ruled out because there is evidence that M. leprae remains 
viable for some time outside of the human body(5). Nine-banded 
armadillos and African monkeys, including chimpanzees, 
sooty mangabeys, and cynomolgus macaques, are the only 
animals other than humans that can be naturally infected with 
M. leprae(6); however, there is no evidence that they could be 
involved in its transmission chain(7). 
Clinically, this disease manifests with localized, multiple 
or disseminated lesions. The histopathology of the skin lesions 
varies from compact granulomas to diffuse inﬁ ltration of the 
dermis, largely depending on the immune status of the patient. 
In some patients, histopathological examination ﬁ ndings may 
not be correlated with the clinical diagnosis(1).
The initial leprosy treatment was lifetime monotherapy 
with dapsone. Later, a combination of dapsone and rifampicin 
was used. However, due to the problem of dapsone resistance 
detected in more than 40 endemic countries, including the State 
of Amazonas(8) during the 1970s and 1980s, in October 1981, the 
World Health Organization (WHO) recommended the introduction 
of a new therapeutic regimen known as the multidrug therapy 
(MDT), which included dapsone, rifampicin and clofazimine(9) (10).
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Following the success of MDT and a steady decline in the 
number of registered patients, in 1991, the WHO adopted a 
resolution calling for the elimination of leprosy as a public 
health problem by the year 2000. The goal was to reduce the 
known prevalence of leprosy to below 1 patient per 10,000 
inhabitants(11). Leprosy was eliminated at the global level by 
the year 2000. However, most endemic countries had not 
reached this elimination goal at that time. Then, a new goal was 
established for elimination by 2005. By the year 2005, Brazil 
was among nine countries that had not eliminated leprosy as a 
public health problem, and its prevalence in this country was 
still over 1/10,000 inhabitants. 
According to the WHO, 219,075 new leprosy cases were 
detected worldwide in 2011. Among the countries that submitted 
reports to the WHO in 2011, India, Brazil and Indonesia reported 
83% of these new cases (58% in India, 16% in Brazil and 9% 
in Indonesia). India and Brazil have experienced very gradual 
declines in the prevalence of this disease since 2006 and 2007, 
respectively. In addition, after maintaining a plateau since 2006, 
Indonesia experienced a signiﬁ cant increase in new cases in 
2011(12).
According to the Brazilian Ministry of Health (BrMoH), 
33,955 new leprosy cases were detected in Brazil in 2011, 
representing a general detection rate of 17.6/100,000 inhabitants. 
The leprosy prevalence in Brazil decreased from 4.52/10,000 
population in 2003 to 1.56/10,000 inhabitants in 2010(13). 
However, according to a study conducted by Penna and Penna 
in 2007, this disease will remain a public health problem until 
the year 2020(14). 
According to the BrMoH, 643 leprosy cases were detected 
in 2011 in the State of Amazonas. Of them, 586 (84.4%) were 
new cases, 66 (9.5%) were relapses, 34 (4.9%) were defaulters 
and 8 (1.2%) were transferred from other states. Among the 
new leprosy cases detected, 256 (45.9%) were from the capital, 
Manaus, and 317 (54.1%) were from other municipalities of 
State of Amazonas. The leprosy prevalence in the Amazonas 
showed a decreasing trend from 1987 to 2011, achieving a 98% 
reduction (from 123.95/10,000 to 2.97/10,000 inhabitants) (13).
At the Alfredo da Matta Center (AMC) for Tropical 
Dermatology and Sexually Transmitted Diseases  which is a 
referral center for the diagnosis and treatment of leprosy in the 
State of Amazonas, 329 leprosy cases were detected in 2011. Of 
them, 256 (77.8%) were new cases, 41 (12.5%) were relapses, 
23 (7%) were defaulters and 9 (2.7%) were transferred from 
other municipalities. The 256 new cases detected at the AMC 
corresponded to 43.7% of the reported cases in State of Amazonas 
and 79.5% of the cases reported in the capital of Manaus(15). These 
data indicate that there is an urgent need to implement even more 
decentralization activities and/or to perform more training and 
supervision throughout the whole state.
HISTORY OF THE DISEASE IN 
THE STATE OF AMAZONAS 
According to comparative genomics studies, leprosy 
originated in Eastern Africa or the Near East and spread with 
successive human migrations. Europeans and North Africans 
introduced leprosy into West Africa and the Americas within 
the past 500 years(16). In Brazil, the disease arrived with the 
colonizers who established the ﬁ rst colonies, Rio de Janeiro, 
Salvador and Recife, at the end of the sixteenth and beginning 
of the seventeenth centuries, and it was then spread to the 
other states. Within years, increasing numbers of patients 
were observed in the provinces of Bahia, Minas Gerais, Pará, 
Pernambuco, Rio de Janeiro and São Paulo, where agriculture 
was the most important economic activity(17).
In the State of Amazonas, the ﬁ rst records of patients 
diagnosed with leprosy are from 1854(17). In approximately 1877, 
the great drought in northeast Brazil caused one of the largest 
human migrations in the country. Rubber extraction was an 
important activity in the Amazon region at that time, resulting 
in an increasing demand for manpower. Many northeastern 
immigrants came to work in this region. Later, during the 
Second World War, more northeastern immigrants arrived in this 
region for work. They were known as rubber soldiers. Similar 
to other states of the Brazilian Amazon basin, rubber extraction 
in the State of Amazonas was commercially more important 
in the Amazon River and its whitewater tributaries, such as 
Jurua, Purus, and Madeira River, among others. Historically, 
the highest number of patients diagnosed with leprosy lived on 
the banks of these rivers. However, the communities living on 
the Negro river, which is a blackwater river, and its tributaries 
always contained a lower number of leprosy patients. Rubber 
extraction was never economically important in the Negro river 
region. Therefore, it is possible that the rubber soldiers and their 
families contributed to the introduction and augmentation of the 
number of leprosy patients in the Amazon Basin(18) (19). 
The increasing number of new cases of this disease in State 
of Amazonas and the need for treatment and disease control 
led authorities to follow national recommendations and create 
special places to isolate leprosy patients. In 1913, after a boat 
expedition throughout the Amazonas Valley, Oswaldo Cruz 
reported a high number of leprosy patients living among the 
healthy population(20). The compulsory isolation policy was 
defended by all local medical elite specialists and also by the 
Amazonas population. Moreover, this measure was undertaken 
in other states of Brazil during the 1910s following a worldwide 
movement to combat leprosy. Umirisal, which was built in 1908, 
was initially used for the isolation of patients with smallpox. 
However, after the development of a vaccine and disease control, 
it was used to house leprosy patients. In 1920, Alfredo da Matta, 
a sanitary rural inspector of leprosy and venereal diseases, 
estimated that there were 800 to 1,000 leprosy patients in the 
state(21). Umirisal was no longer sufﬁ cient to house all of the 
patients. Thus, a new leprosarium, Paricatuba, was built on the 
riverbanks of the Negro River(17) (22). 
On April 26th, 1922, a daycare called Alice Sales was 
established in the neighborhood of Cachoerinha in Manaus 
to assist the children of leprosy patients. At that time, some 
segregationist control measures had already been adopted 
involving household contacts, and the children of patients were 
separated from their parents at birth. The Educandário Gustavo 
Capanema was another daycare institution built to support the 
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children of leprosy patients in Manaus. This segregation was 
considered necessary to break the transmission chain in families. 
Thus, thousands of families were destroyed; leprosy patients 
were sent to leprosaria, and children were separated from their 
families(17) (22).
In 1934, a large national crusade to control leprosy was 
initiated. The State of Amazonas was also involved, and local 
action was supervised by Alfredo da Matta. Throughout his 
career, he wrote several documents emphasizing the importance 
of leprosy in State of Amazonas. Apparently, the national leprosy 
control committee did not realize how serious the leprosy 
situation was in this state21.
In 1965, the leprosy patients isolated at Paricatuba 
leprosarium were transferred to a new place, named Colônia 
Antônio Aleixo. This leprosarium was built according to the 
most advanced recommendations for isolation at that time(17) (22). 
On March 12th, 1966, by the request of the Amazonas 
State Health Administration, the Franciscan Missionaries of 
Mary, an organization of the Catholic Church, began working 
in a new leprosarium to provide care and support for leprosy 
patients(23). Due to alarming reports by the newspapers and 
radios at that time of the indifference of authorities to leprosy, 
the local government, with the support of the BrMoH, the WHO 
and international funding, began offering better assistance 
to patients(24). Between 1974 and 1975, a multidisciplinary 
medical team composed of dermatologists (Sinésio Talhari, 
Mario Ewerton and Maria da Graça Cunha), an ophthalmologist 
(Eugênio Aubert), an orthopedist (Leonildo Rodrigues) and an 
otorhinolaryngologist (Renato Telles) began working at Colônia 
Antônio Aleixo(22), and the total population of approximately 
1,600 leprosy patients was reduced to less than 650 patients. 
At that time, several treated and cured patients who were still 
living in the leprosarium were also released(18).
Currently, there is a small community living around the 
ruins of the main buildings of the Paricatuba leprosarium(22). 
The area of the Colônia Antônio Aleixo leprosarium became 
a neighborhood of Manaus with an estimated population of 
18,000 inhabitants(25). 
The history of the AMC parallels the history of leprosy 
in the state. In 1954, due to the success obtained with the use 
of sulfone, the Brazilian Government allocated funds for the 
installation of leprosy dispensaries in the region. In August 
1955, the Alfredo da Matta Dispensary was inaugurated in 
Manaus(22). Progressively, the Alfredo da Matta Dispensary 
intensiﬁ ed and expanded its outpatient activities, and after 1975, 
it became a center for dermatological and sexually transmitted 
diseases. On November 24th, 1982, the dispensary was 
ofﬁ cially recognized as the AMC and took responsibility for the 
management of the Amazonas leprosy control program. More 
dermatologists, physiotherapists, nurses, and health technicians 
were recruited. Intense leprosy control activities in Manaus and 
other municipalities of the state started began these changes. 
Figure 1 shows the increasing number of new patients diagnosed 
and the improvement of the quality of the sustainable leprosy 
control program after the implementation of MDT, which was 
a new therapeutic regimen for leprosy recommended by the 
WHO in 1981(9). The State of Amazonas was one of the ﬁ rst 
Brazilian States to implement MDT. In 1982, it was initiated 
at the AMC as a standard therapy for leprosy, mainly because 
sulfone resistance had already been conﬁ rmed in leprosy patients 
from Colônia Antônio Aleixo(8). In addition to the AMC, the 













































































































FIGURE 1 - New leprosy cases detected in the State of Amazonas from 1935-2012.
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participated in the program and centers from other municipalities 
of the State of Amazonas were initiated in 1985. Amazonas is 
the largest Brazilian state by area (1,570,745,600km2), with 
an estimated population in 2013 of 3,807,921 inhabitants. 
Manaus, which is the capital, is secluded by a rain forest, and 
transportation to other municipalities occurs mainly by boat or 
airplane(25). Despite the efﬁ cacy and widespread use of MDT 
in the Amazonas, most of the municipalities are very large in 
size, and one of the main difﬁ culties encountered by patients 
is the time spent traveling from rural zones to town centers 
for monthly MDT supervision. Therefore, leprosy control has 
proven to be challenging in this region due to difﬁ culties in 
reaching the high endemic areas of the state. Over the years, 
training programs for health professionals have been conducted 
regularly in Manaus and in other municipalities of the state that 
include regular 5-10 day courses on the general aspects of the 
disease and MDT led by AMC staff(26).
The AMC still facilitates the diagnosis, treatment, and 
prevention of leprosy disabilities and provides rehabilitation 
services, and it has became one of the best training centers for 
leprosy, general dermatology and sexually transmitted diseases 
in Brazil. Additionally, the center is a national and WHO referral 
center for the diagnosis and treatment of leprosy.
EPIDEMIOLOGICAL TRENDS IN 
THE STATE OF AMAZONAS
In the period prior to the deactivation of the leprosy colonies, 
there was a ﬂ uctuation in the detection of rate data, which was 
likely because the quality of the routine case detection data 
was not sufﬁ cient to ensure for consistency and comparability 
within a period time series (Figure 1). After the eradication 
of the leprosaria in the State of Amazonas, the leprosy data 
became more consistent. Analysis of the period time series 
revealed increases in the detection rate over the years. From 
the early 1980s, the rate increased up to 77%, and changes over 
time were observed. Since 2000, the disease has behaved in a 
more stable manner, with a decreasing trend in the detection 
rate; for example, in the State of Amazonas, it dropped from 
45.1/100,000 to 18.1/100,000 inhabitants in 2012, representing 
a decrease of 59.8%. According to the BrMoH parameters, the 
state remained hyperendemic (≥40.0/100,000 inhabitants) until 
2002, despite the important reduction in detection. Figure 2 
shows that in 2003, the state showed a very high coefﬁ cient of 
endemicity (40.0┤20.0/100,000 inhabitants), which currently 
remains high (20.0┤10.0/100,000 inhabitants) (15).
The detection rate in children under 15 years of age in the 
Amazonas was very high and showed an unstable pattern, 
similar to the overall rate (Figure 3). In endemic areas such 
as the State of Amazonas, children are exposed to leprosy 
bacillus at an early age; thus, intense transmission increases 
the occurrence of leprosy cases in this speciﬁ c population. 
Therefore, the leprosy detection rate in children under 15 years 
is an indicator of transmissibility and determines the trend of 
endemicity, reﬂ ecting the severity of an endemic. In recent years, 
this coefﬁ cient has declined. However, according to the BrMoH 
parameters, the state remained at hyperendemic levels until 
2004 (≥10.0/100,000 inhabitants), with high detection rates in 
children. From 2005, there was a very high level of endemicity 
(10.0┤5.0/100,000 inhabitants). According to a historical data 
series from the 1990s, the state showed a decreasing trend 
in detection rates, from 35.2/100,000 inhabitants in 1990 to 
5.8/100,000 inhabitants in 2012. Although this rate was reduced 
by 83.5%, the state still shows high leprosy detection rates 
among children(15).











































































































FIGURE 2 - Leprosy detection coefﬁ cients in State of Amazonas from 1935-2012.
Cunha C et al. - Historical aspects of leprosy in State of Amazonas, Brazil













































































































YearSource: SINAN/Fundação Alfredo da Matta
FIGURE 3 - Leprosy detection rates among children in the State of Amazonas from 1935-2012.
In 1978, the leprosy prevalence in the State of Amazonas 
(Figure 4) was 79.8/10,000 inhabitants, increasing gradually 
until 1988, when it reached the highest level of the entire 
historical data series of 129.0/10,000 inhabitants. During this 
period, despite the introduction of MDT, the number of patients 
released from the registry was small due to long treatment 
courses and the national guidelines for releasing leprosy cases 
for cured or defaulter patients. At this time, the predominant 
treatment was not MDT, and patients undergoing other therapies, 
depending on the clinical form, remained under surveillance 
after treatment indeﬁ nitely. Even those who were under MDT 
and ﬁ nished treatment were kept on the registry for years.
Despite the abovementioned operational problems, the 
introduction of MDT in the State of Amazonas led to a 
tremendous decrease in leprosy prevalence from 129/10,000 
inhabitants in 1988 to 2.8/10,000 inhabitants in 2012 
(Figure 4). This reduction of 97.8% also occurred due to the 
application of revised national guidelines related to the release 
of defaulters from the registry. These regulatory measures 
have been altered over the years, resulting in shorter treatment 
times, the abolition of post-treatment follow-up and a shorter 
duration for the removal of defaulter patients from the active 
record. Therefore, although the prevalence data generated are 
useful for monitoring leprosy elimination, they may not reﬂ ect 
the actual epidemiological situation of the disease because they 
are strongly inﬂ uenced by operational issues(26) (27).
In 2012, an increasing number of new cases of leprosy were 
diagnosed in several municipalities of Amazonas state as part of 
an active case-ﬁ nding program conducted by dermatologists and 
healthcare personnel from the AMC(28). In many municipalities, 
the number of cases diagnosed by the AMC staff in only one 
visit was higher than the total number of cases diagnosed in 
the previous months (Table 1). These data demonstrate that 
underdiagnosis occurs in the State of Amazonas. Moreover, 
it indicates that at least in these municipalities, leprosy 
transmission is still an important issue. 
According to the present situation, there are two possible 
explanations for the reductions in the prevalence and incidence 
of this disease in the State of Amazonas: 1) although it is still an 
endemic state, the current reduction of new cases points towards 
a decrease in leprosy transmission as a direct consequence of 
MDT implementation; or 2) underdiagnosis might be occurring 
due to a decrease in leprosy control program activities in the 
health centers of the capital and other municipalities of the 
State of Amazonas. Analysis of recent data obtained in different 
municipalities of the State of Amazonas suggests the possibility 
of underdiagnosis and the necessity of intensifying training and 
supervision activities.
PERSPECTIVES AND CONCLUSIONS
Many facts have been reported in the literature in the remote 
history of leprosy, ranging from its identiﬁ cation as an incurable 
disease considered as God’s punishment to the possibility of a 
Rev Soc Bras Med Trop 48(Suppl I):55-62, 2015
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TABLE 1 - Leprosy cases diagnosed by the Alfredo da Matta staff in 2012 in the municipalities of the State of Amazonas.
 Leprosy cases diagnosed by local Leprosy cases Diagnosed by 
 diagnosed in health staff diagnosed by AMC staff in AMC staff in 2012
Municipality 2011 in 2012 2012 in one single visit n %
Autazes 5 3 7 10  70.0 
Atalaia do Norte 4 0 5 5  100.0 
Benjamin Constant 10 5 2 7  28.6 
Careiro 6 1 4 5  80.0 
Careiro da Várzea 1 0 3 3  100.0 
Coari 23 15 16 31  51.6 
Humaitá 24 17 19 36  52.8 
Itapiranga 2 0 5 5  100.0 
Iranduba 10 1 1 2  50.0 
Itacoatiara  24 34 1 35  2.9 
Lábrea 7 7 3 10  30.0 
Manacapuru 8 8 8 16  50.0 
Manaquiri 1 0 4 4  100.0 
Manicoré 8 6 12 18  66.7 
Novo Airão 0 0 2 2  100.0 
Novo Aripuanã 7 2 16 18  88.9 
Parintins 32 30 5 35  14.3 
Presidente Figueiredo 9 8 1 9  11.1 
Rio Preto da Eva 1 1 1 2  50.0 
Silves 2 1 2 3  66.7 
Total 184 139 108 247  43.7 
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FIGURE 4 - Leprosy prevalence coefﬁ cients in State of Amazonas from 1978-2012.
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single-dose treatment for some patients. The decoding of the 
M. leprae genome(29) has introduced a broad new ﬁ eld of research 
and has led to an increased understanding of the involvement of 
genetics in the pathophysiology of this disease(30). 
Despite these advances, many old doubts and questions 
remain unanswered, and there is much to learn and teach 
clinicians with regard to how to diagnose and manage leprosy 
patients(31) (32) (33).
The data presented in this paper clearly show that 
decentralization as deﬁ ned by the BrMoH did not occur in the state 
despite all of the efforts of the AMC staff. The institution is one 
of the few in the world that can provide important information on 
this disease by performing high-quality research. It is essential that 
the AMC continues to provide assistance to most of the patients 
from Manaus; therefore, decentralization is not an effective 
strategy to achieve the goals of this institution because the goals 
cannot be reached without patients and a great assistance team. 
Gradually, the expertise of the AMC will be diminished by the 
loss of experts due to retirement. Therefore, patient assistance 
must be provided at the AMC as frequently as possible and the 
effects of decentralization on science and expertise in the state 
must be demonstrated, or else its training and research capacities 
will slowly disappear. A high quality of scientiﬁ c research is 
completely dependent on a good quality of assistance.
Finally, leprosy is an ancient disease that still has a high 
detection rate in remote areas, such as the State of Amazonas, 
and despite intense research efforts in the last centuries, it is 
not yet fully understood. Therefore, much progress still needs to 
be achieved before realistic (not statistical) elimination occurs.
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